Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminum phosphate is an inorganic compound with the formula AlPO₄, typically appearing as a white, odorless crystalline solid. It is widely used in medicine as an antacid to neutralize stomach acid and relieve symptoms of gastric ulcers and hyperacidity. In addition, it serves as an immunologic adjuvant in vaccines to enhance immune response. Aluminum phosphate’s mechanism of action as an antacid involves direct chemical neutralization of gastric hydrochloric acid, while its role as a vaccine adjuvant is attributed to its ability to stimulate the immune system and improve antigen presentation. Beyond pharmaceuticals, it finds applications in ceramics, dental cements, pigments, corrosion inhibitors, molecular sieves/catalysts for industrial processes, and food additives (as a leavening agent)[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminum phosphate.